Edwards Lifesciences CorporationEWNYSE
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+10.0%
5Y CAGR+11.1%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+10.0%/yr
vs +9.6%/yr prior
5Y CAGR
+11.1%/yr
Consistent
Acceleration
+0.4pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.7x
Solid growth
Streak
5 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $2.09B | +16.5% |
| 2024 | $1.79B | +13.1% |
| 2023 | $1.58B | +1.0% |
| 2022 | $1.57B | +5.0% |
| 2021 | $1.49B | +21.3% |
| 2020 | $1.23B | -0.9% |
| 2019 | $1.24B | +14.4% |
| 2018 | $1.09B | +9.8% |
| 2017 | $989.70M | +9.9% |
| 2016 | $900.20M | - |